CN113559133A - Liquid drop for preventing diarrhea, enhancing immunity, resisting infection and treating dermatitis - Google Patents
Liquid drop for preventing diarrhea, enhancing immunity, resisting infection and treating dermatitis Download PDFInfo
- Publication number
- CN113559133A CN113559133A CN202110983910.6A CN202110983910A CN113559133A CN 113559133 A CN113559133 A CN 113559133A CN 202110983910 A CN202110983910 A CN 202110983910A CN 113559133 A CN113559133 A CN 113559133A
- Authority
- CN
- China
- Prior art keywords
- liquid drop
- enhancing immunity
- diarrhea
- infection
- dermatitis
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
- A61K35/741—Probiotics
- A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
- A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
- A61K31/225—Polycarboxylic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/12—Antidiarrhoeals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
- A61P39/02—Antidotes
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- General Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Epidemiology (AREA)
- Immunology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Pulmonology (AREA)
- Emergency Medicine (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Oncology (AREA)
- Dispersion Chemistry (AREA)
- Communicable Diseases (AREA)
- Toxicology (AREA)
- Nutrition Science (AREA)
- Physiology (AREA)
- Molecular Biology (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Abstract
The invention discloses a liquid drop for preventing diarrhea, enhancing immunity, resisting infection and treating dermatitis, which is prepared from the following raw materials in volume ratio: 1-5% of lactobacillus rhamnosus and 95-99% of medium chain triglyceride. The invention can effectively prevent diarrhea, enhance immunity, resist infection and treat dermatitis.
Description
Technical Field
The invention relates to the technical field of probiotics, in particular to a liquid drop for preventing diarrhea, enhancing immunity, resisting infection and treating dermatitis.
Background
Inflammation is the most fundamental pathological process of infection and many diseases. Generally, inflammation is beneficial and is an automatic defense response of the human body, but an excessive inflammatory response is also harmful, for example, many inflammatory factors secreted by a long-term inflammatory response may cause damage to normal tissues, promote tumorigenesis, and the like. Immunity and inflammation are two aspects of a problem, and the high and low of immunity determines the health degree of a human. The immunity of human body depends partly on genetic genes and partly on the influence of environment, such as diet, sleep, exercise, pressure and the like, wherein probiotic food and health care products in diet are important research targets for regulating immunity in recent years. Therefore, the liquid drop for preventing diarrhea, enhancing immunity, resisting infection and treating dermatitis is developed by the inventor.
Disclosure of Invention
The invention aims to provide a liquid drop for preventing diarrhea, enhancing immunity, resisting infection and treating dermatitis, which can effectively prevent diarrhea, enhance immunity, resist infection and treat dermatitis.
In order to solve the technical problems, the invention adopts the following technical scheme:
the invention provides a liquid drop for preventing diarrhea, enhancing immunity, resisting infection and treating dermatitis, which is characterized by being prepared from the following raw materials in volume ratio: 1-5% of lactobacillus rhamnosus and 95-99% of medium chain triglyceride.
The invention also relates to a preparation method of the liquid drop for preventing the virus infection of the mammals and treating the intestinal diarrhea, which comprises the following specific steps:
step 1: preparing raw materials of lactobacillus rhamnosus and medium-chain triglyceride according to a certain proportion;
step 2: mixing the two materials, stirring at 45 deg.C below 45 deg.C, suspending completely, and bottling.
The using method comprises the following steps: one to two drops per administration, corresponding to 0.5 ml.
The invention has the beneficial effects that: can effectively prevent diarrhea, enhance immunity, resist infection and treat dermatitis.
The following further explains the beneficial effects of the present invention in combination with the efficacy of the main ingredients in the present invention:
bifidobacterium lactis: 1. can balance and improve gastrointestinal function; 2. can enhance the immunity of the human body; 3. can promote the growth and action of bifidobacterium and lactobacillus acidophilus; 4. can be used for preventing and treating diarrhea; 5. can prevent respiratory tract infection; 6. toxins can be eliminated; 7. it can also prevent allergy.
Medium chain triglycerides: the medium chain triglyceride has functions of supplying body and storing energy, and has functions of fixing and protecting viscera.
Detailed Description
The technical solutions of the present invention will be described clearly and completely in the following embodiments of the present invention, and it should be understood that the described embodiments are only a part of the embodiments of the present invention, and not all of the embodiments. All other embodiments, which can be derived by a person skilled in the art from the embodiments given herein without making any creative effort, shall fall within the protection scope of the present invention.
Example 1
A liquid drop for preventing diarrhea, enhancing immunity, resisting infection and treating dermatitis is prepared from the following raw materials: lactobacillus rhamnosus 2% and medium chain triglyceride 98%.
The preparation method of the liquid drop for preventing diarrhea, enhancing immunity, resisting infection and treating dermatitis comprises the following specific steps:
step 1: preparing milk bifidobacterium and medium-chain triglyceride as raw materials in proportion;
step 2: mixing the two raw materials, stirring for 45 min at 30 deg.C, suspending completely and uniformly, and bottling.
Example 2
A liquid drop for preventing diarrhea, enhancing immunity, resisting infection and treating dermatitis is prepared from the following raw materials: 1% of lactobacillus rhamnosus and 99% of medium-chain triglyceride.
The preparation method of the liquid drop for preventing diarrhea, enhancing immunity, resisting infection and treating dermatitis comprises the following specific steps:
step 1: preparing milk bifidobacterium and medium-chain triglyceride as raw materials in proportion;
step 2: mixing the two raw materials, stirring for 45 min at 40 deg.C, suspending completely and packaging.
Example 3
A liquid drop for preventing diarrhea, enhancing immunity, resisting infection and treating dermatitis is prepared from the following raw materials: 3% of lactobacillus rhamnosus and 97% of medium-chain triglyceride.
The preparation method of the liquid drop for preventing diarrhea, enhancing immunity, resisting infection and treating dermatitis comprises the following specific steps:
step 1: preparing milk bifidobacterium and medium-chain triglyceride as raw materials in proportion;
step 2: mixing the two raw materials, stirring for 45 min at 32 deg.C, suspending completely and packaging.
Clinical trials applying the present invention:
the test persons had 120 cases, wherein 60 cases of men and 60 cases of women were aged 10-55 years, 30 cases of men and women with diarrhea, and 30 cases of men and women with dermatitis, and 120 cases were divided into 3 groups, and the 3 groups were similar as much as possible to make them comparable.
The treatment method comprises the following steps: the diarrhea patients take the medicine once a day, one drop at a time, and observe the medicine after half a month; the dermatitis patients take the medicine once a day, two drops are taken each time, and the observation is carried out after 2 months.
Diagnostic criteria
The method has the following advantages: diarrhea and dermatitis are improved.
As a result: in example 1, 120 testers and 118 testers are effective, and the effective rate is 98.3%.
In example 2, 120 testers, 117 effective, 97.5% effective rate.
In example 3, 120 testers, 115 effective, 95.8% effective rate.
It will be apparent to those skilled in the art that various changes and modifications may be made in the present invention without departing from the spirit and scope of the invention. Thus, if such modifications and variations of the present invention fall within the scope of the claims of the present invention and their equivalents, the present invention is also intended to include such modifications and variations.
Claims (1)
1. The liquid drop for preventing diarrhea, enhancing immunity, resisting infection and treating dermatitis is characterized by being prepared from the following raw materials in volume ratio: 1-5% of lactobacillus rhamnosus and 95-99% of medium chain triglyceride.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202110983910.6A CN113559133A (en) | 2021-08-25 | 2021-08-25 | Liquid drop for preventing diarrhea, enhancing immunity, resisting infection and treating dermatitis |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202110983910.6A CN113559133A (en) | 2021-08-25 | 2021-08-25 | Liquid drop for preventing diarrhea, enhancing immunity, resisting infection and treating dermatitis |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN113559133A true CN113559133A (en) | 2021-10-29 |
Family
ID=78172686
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN202110983910.6A Pending CN113559133A (en) | 2021-08-25 | 2021-08-25 | Liquid drop for preventing diarrhea, enhancing immunity, resisting infection and treating dermatitis |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN113559133A (en) |
Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2250912A1 (en) * | 2009-05-06 | 2010-11-17 | Oriola, OY | A health-enhancing preparation administrable in the form of drops, and a method for preparing the same |
| CN109820044A (en) * | 2018-07-13 | 2019-05-31 | 拜尔普兰（厦门）生物药业有限公司 | A kind of strengthen immunity and assist antianaphylactic probiotics solid beverage formula |
| CN110583936A (en) * | 2019-10-19 | 2019-12-20 | 上海英库商务咨询有限公司 | Rhamnose bacillus drinking liquid and its preparing method |
-
2021
- 2021-08-25 CN CN202110983910.6A patent/CN113559133A/en active Pending
Patent Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2250912A1 (en) * | 2009-05-06 | 2010-11-17 | Oriola, OY | A health-enhancing preparation administrable in the form of drops, and a method for preparing the same |
| CN109820044A (en) * | 2018-07-13 | 2019-05-31 | 拜尔普兰（厦门）生物药业有限公司 | A kind of strengthen immunity and assist antianaphylactic probiotics solid beverage formula |
| CN110583936A (en) * | 2019-10-19 | 2019-12-20 | 上海英库商务咨询有限公司 | Rhamnose bacillus drinking liquid and its preparing method |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Oak et al. | The effects of probiotics in lactose intolerance: A systematic review | |
| CN111004733A (en) | Bacillus coagulans composite microecological preparation with constipation relieving function | |
| CN109432136A (en) | A kind of probiotic combinations preparation and its preparation method and application | |
| Georgieva et al. | Probiotics and immunity | |
| CN111374896A (en) | Prebiotics and probiotic skin care product for treating acne and preparation method thereof | |
| CN111802631A (en) | Green multi-vitamin nutrient and preparation method thereof | |
| CN110859871A (en) | Composition for treating prostatitis and preparation method thereof | |
| CN110075226A (en) | It is a kind of can be with the probiotic composition of reducing blood lipid | |
| CN113575964A (en) | Antioxidant and anti-aging probiotic composition and preparation method thereof | |
| CN110960561B (en) | Probiotic composition for regulating balance of gynecological flora | |
| KR20170045247A (en) | Lactic acid bacteria-containing composition | |
| CN112244300A (en) | Immunoregulation composition containing probiotics as well as preparation method and application thereof | |
| CN107279234A (en) | The biscuit of healthy intestinal health | |
| CN113559133A (en) | Liquid drop for preventing diarrhea, enhancing immunity, resisting infection and treating dermatitis | |
| CN105534948B (en) | A kind of vagina active bacteria formulation and preparation method thereof being stored at room temperature | |
| KR102239890B1 (en) | Manufacturing Method of Promoter for Preventing Alopecia and Hair Growth through Fusion Fermentation of Lactic Acid Bacteria | |
| CN114177265A (en) | Composition for preventing and/or treating Alzheimer's disease and preparation method and application thereof | |
| CN106943635A (en) | A kind of human body lubricants preparation method based on probiotic bacterial cultures | |
| CN111296842A (en) | Probiotic composition with anti-allergy effect | |
| RU2589843C2 (en) | Agent for treating intestinal infections and conditions caused by dysbacteriosis, "biobalance a" | |
| CN110050972A (en) | Aloe haw pellet and preparation method thereof | |
| CN114672441B (en) | Lactic acid bacteria composition and application thereof | |
| CN113730546B (en) | Pharmaceutical composition for treating parkinsonism and application thereof | |
| CN117025479B (en) | Lactobacillus gasseri SHMB A0001 and application thereof in preventing and relieving acute colitis | |
| CN107233477A (en) | A kind of composition, preparation method and application method for being used to treat porcine respiratory |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination |